pharma decision making

The 60% Blind Spot: Why Most Patient Services Data Never Informs Decisions Pharmaceutical companies today invest heavily in patient services programs covering access support, copay assistance, adherence monitoring, and more. These initiatives generate mountains of patient level data, ranging from prescription fill rates to call center interactions. Yet, research shows that up to 60% of […]